Cargando…
Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway
The aggressive nature of triple negative breast cancer (TNBC) may be explained in part by the presence of breast cancer stem cells (BCSCs), a subpopulation of cells, which are involved in tumor initiation, progression, metastasis, recurrence, and therapy resistance. The signal transducer and activat...
Autores principales: | Rios-Fuller, Tiffany J., Ortiz-Soto, Gabriela, Lacourt-Ventura, Mercedes, Maldonado-Martinez, Gerónimo, Cubano, Luis A., Schneider, Robert J., Martinez-Montemayor, Michelle M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267592/ https://www.ncbi.nlm.nih.gov/pubmed/30542507 http://dx.doi.org/10.18632/oncotarget.26294 |
Ejemplares similares
-
Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression
por: Suárez-Arroyo, Ivette J., et al.
Publicado: (2016) -
Identification of Biologically Active Ganoderma lucidum Compounds and Synthesis of Improved Derivatives That Confer Anti-cancer Activities in vitro
por: Martínez-Montemayor, Michelle M., et al.
Publicado: (2019) -
Anti-Tumor Effects of Ganoderma lucidum (Reishi) in Inflammatory Breast Cancer in In Vivo and In Vitro Models
por: Suarez-Arroyo, Ivette J., et al.
Publicado: (2013) -
Ganoderma lucidum Extract Reduces the Motility of Breast Cancer Cells Mediated by the RAC–Lamellipodin Axis
por: Acevedo-Díaz, Ariana, et al.
Publicado: (2019) -
Triterpenoids from the spores of Ganoderma lucidum
por: Ma, Bingji, et al.
Publicado: (2011)